Lindsey Allen | executive |
Justin Klee | executive |
Camille Bedrosian | executive |
James Frates | executive |
Joshua Cohen | executive |
Graig Suvannavejh | analyst |
Good morning. My name is Morgan, and I will be your conference operator today. At this time, I would like to welcome everyone to the Amylyx Pharmaceuticals First Quarter 2024 Earnings Conference Call. [Operator Instructions] Please be advised that this call is being recorded at the company's request. I would now like to turn the call over to your host, Lindsey Allen, Head of Investor Relations and Communications. Please proceed.